Workflow
Astrana Health, Inc. Reports Third Quarter 2025 Results
Prnewswire· 2025-11-07 05:05
Accessibility StatementSkip Navigation Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Nov. 6, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the t ...
Direct Digital Holdings Announces Expansion of its Equity Reserve Facility to $100 Million
Prnewswire· 2025-11-07 05:05
Accessibility StatementSkip Navigation HOUSTON, Nov. 6, 2025 /PRNewswire/ -- Direct Digital Holdings, Inc. (Nasdaq: DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC ("Colossus SSP") and Orange 142, LLC ("Orange 142"), today announced that it has entered into an amendment to its existing Equity Reserve Facility to expand the capacity to $100 million from $20 million. The expansion of the Equity Rese ...
DIAMONDROCK HOSPITALITY COMPANY REPORTS THIRD QUARTER 2025 RESULTS
Prnewswire· 2025-11-07 05:05
Accessibility StatementSkip Navigation Raises Midpoint of 2025 Adjusted EBITDA and Adjusted FFO Guidance Repurchased 4.8 Million Common Shares Year To Date BETHESDA, Md., Nov. 6, 2025 /PRNewswire/ -- DiamondRock Hospitality Company (NYSE: DRH) (the "Company"), a lodging real estate investment trust that owns a portfolio of 36 premium hotels and resorts in the United States, today announced results of operations for the quarter ended September 30, 2025. HIGHLIGHTS "We are pleased to report that third quarter ...
10x Genomics Reports Third Quarter 2025 Financial Results
Prnewswire· 2025-11-07 05:05
PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2025. Accessibility StatementSkip Navigation 10x Genomics expects fourth quarter 2025 revenue to be in the range of $154 million to $158 million, representing a 6% decline from the corresponding prior year period and 5% growth sequentially at the midpoint. Recent Updates "Our team delivered a solid third qu ...
Sunrun Announces Appointment of Craig Cornelius to its Board of Directors
Globenewswire· 2025-11-07 05:02
SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), America’s largest provider of home battery storage, solar, and home-to-grid power plants, today announced the appointment of Craig Cornelius as a member of Sunrun’s board of directors (the “Board”). Mr. Cornelius brings two decades of industry experience across the renewable energy space. “I am excited to announce the appointment of Craig as our newest board member. Craig brings a wealth of experience and perspective, having led large, c ...
Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Globenewswire· 2025-11-07 05:02
Data from the recent Phase 2 study position Ventyx’s NLRP3 inhibitor VTX3232 as a next generation, oral anti-inflammatory therapy, for cardiovascular disease Positive topline data from Phase 2a biomarker trial support the potential use of VTX3232 as a disease-modifying therapy for patients with Parkinson’s diseaseTopline data from Phase 2 study of VTX2735 in patients with recurrent pericarditis expected in Q4 2025Cash, cash equivalents and marketable securities balance of $192.6M as of September 30, 2025, e ...
Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Prnewswire· 2025-11-07 05:02
Accessibility StatementSkip Navigation SHELTON, Conn., Nov. 6, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system recognition of cancers using its proprietary non-covalent conjugation technology, announces third quarter 2025 financial results and provides a corporate update. Corpor ...
AMD Stock After Strong Q3 Earnings - Still a Buy or Overvalued?
ZACKS· 2025-11-07 05:01
Key Takeaways AMD's Q3 revenues jumped 36% to $9.25B, with data center, client, and gaming units surpassing expectations.Partnerships with OpenAI and Oracle will expand AMD's AI data center presence using Instinct MI450 GPUs.Despite growth prospects, AMD trades at 65.15x forward earnings, suggesting potential overvaluation risk.Advanced Micro Devices, Inc. (AMD) recently reported a blowout third quarter and raised its outlook, driven by strong demand for its high-performance EPYC and other products. The com ...
EchoStar Ups Stake In Elon Musk's SpaceX To $11B; Charlie Ergen Returns As CEO Of Dish Network Parent
Deadline· 2025-11-07 05:01
EchoStar has sold another $2.6 billion in spectrum to Elon Musk’s SpaceX, giving the wireless and pay-TV company a stake of about 3% that is currently worth $11 billion. The transaction, announced Thursday along with the company’s third-quarter results, builds on a $17 billion spectrum deal between the companies last September. On the SpaceX end, it makes Musk a bigger player in the wireless business. In addition to the financials and the spectrum deal, the company announced that co-founder and chairman Ch ...
USA Rare Earth Reports Third Quarter 2025 Financial Results
Globenewswire· 2025-11-07 05:01
STILLWATER, Okla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company) today announced its financial and operational results for the third quarter and nine months ended September 30, 2025. Third Quarter Highlights Business Highlights Identified a flow sheet for the Round Top development project, validated through bench- and pilot-scale testing, supporting a targeted Pre-Feasibility Study completion in the second half of 2026.Stillwater, Oklahoma magnet facility remain ...